At a glance
- Originator Daiichi Pharmaceutical; Essential Therapeutics [CEASED]
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action Membrane protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pseudomonal infections